首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Dendrimers as potential drug carriers. Part II. Prolonged delivery of ketoprofen by in vitro and in vivo studies.
【24h】

Dendrimers as potential drug carriers. Part II. Prolonged delivery of ketoprofen by in vitro and in vivo studies.

机译:树状聚合物作为潜在的药物载体。第二部分通过体外和体内研究延长了酮洛芬的递送。

获取原文
获取原文并翻译 | 示例
           

摘要

Ketoprofen, a non-steroidal anti-inflammatory drug with well-known anti-inflammatory, antipyretic and analgesic properties, has low solubility in water and causes local or systemic disturbance in the gastrointestinal tract. In the present study we investigated the potential of polyamidoamine (PAMAM) dendrimers as drug carriers of ketoprofen by in vitro and in vivo studies. The in vitro release of ketoprofen from the drug-dendrimer complex is significantly slower compared to pure ketoprofen. Anti-nociceptive studies using the acetic acid-induced writhing model in mice showed a prolonged pharmacodynamic behavior for the ketoprofen-PAMAM dendrimer complex. Also, the blood level studies were investigated. We concluded that PAMAM dendrimers might be considered as a potential drug carrier of ketoprofen with a sustained release behavior under suitable conditions.
机译:酮洛芬是一种非甾体类抗炎药,具有众所周知的抗炎,解热和镇痛作用,在水中的溶解度低,会引起胃肠道局部或全身性紊乱。在本研究中,我们通过体外和体内研究,研究了聚酰胺酰胺(PAMAM)树状聚合物作为酮洛芬的药物载体的潜力。与纯酮洛芬相比,酮洛芬从药物树状大分子复合物中的体外释放明显较慢。在小鼠中使用乙酸诱导的扭体模型进行的抗伤害感受研究表明,酮洛芬-PAMAM树状聚合物复合物的药代动力学行为延长。此外,还对血液水平研究进行了调查。我们得出的结论是,PAMAM树状聚合物可能被认为是酮洛芬的潜在药物载体,并在适当条件下具有持续释放行为。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号